CLDX vs ROK · rev $37.0K vs P/E 48, rev $8.34B
Celldex Therapeutics Inc (CLDX) versus Rockwell Automation Inc (ROK) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Rockwell Automation Inc (ROK) is a specialty industrial machinery company listed on NYSE.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
Latest reported ROK revenue for 2025-09-30 was $8.34B. Net income was $749.0M. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
CLDX currently screens at market cap $2.35B. ROK currently screens at market cap $51.04B and trailing P/E 47.5.
Not investment advice. Open the CLDX and ROK stock pages for the full models.
Not investment advice.